GRP
TGTX icon

Global Retirement Partners’s TG Therapeutics TGTX Stock Holding History

Global Retirement Partners’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$934 Buy
+17
New +$696 ﹤0.01% 4199
2025
Q4 		$3.19K Sell
107
-265
-71% -$8.65K ﹤0.01% 3578
2025
Q3 		$13.4K Buy
372
+265
+248% +$8.73K ﹤0.01% 2573
2025
Q2 		$3.85K Buy
+107
New +$3.98K ﹤0.01% 3004
2024
Q4 		$3.01K Sell
100
-500
-83% -$14.3K ﹤0.01% 2919
2024
Q3 		$14K Buy
+600
New +$13.1K ﹤0.01% 2157
2024
Q1 		– Sell
-828
Closed -$12.6K – 3479
2023
Q4 		$12.6K Buy
+828
New +$9.62K ﹤0.01% 1968

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Global Retirement Partners's TGTX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in TG Therapeutics (TGTX) in Q2 2026: 17 shares worth $934. The stake represents ﹤0.01% of the portfolio and ranks #4199 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in TGTX as recently as Q4 2025.

Global Retirement Partners first reported a position in TGTX in Q4 2023 and has held it in 7 quarters since. The position peaked at $14K in Q3 2024. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Global Retirement Partners held 17 shares of TG Therapeutics worth $934 as of Q2 2026.
  • TG Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • TG Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4199 holding.
  • Global Retirement Partners first reported a position in TG Therapeutics in Q4 2023 and has held it in 7 quarters since.
  • Global Retirement Partners's TG Therapeutics position peaked at $14K in Q3 2024.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.